Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Express Scripts
Daiichi Sankyo

Generated: May 24, 2018

DrugPatentWatch Database Preview

Claims for Patent: 4,021,481

« Back to Dashboard

Summary for Patent: 4,021,481
Title: Amido derivatives of 2,4,6-triiodobenzoic acids containing at least one N-hydroxyalkyl and at least two hydroxyl groups
Abstract:This invention relates to novel X-ray contrast agents particularly for use in the cerebrospinal cavities, comprising non-ionic alkanols carrying at least one N-bonded secondary or tertiary amide group and having at least two hydroxyl groups and at least one iodine atom in the molecule. Particularly useful compounds include the N-hydroxyalkyl iodoalkane sulphonamides having at least two hydroxyl groups, tri- and tetra-iodobenzene carrying carbamoyl, acylamino and/or acylaminomethyl substituents and having at least two hydroxyl groups in the molecule and at least one N-hydroxyalkyl group. Particularly preferred compounds comprise 2,4,6-triiodobenzamides which may be 3- and/or 5-substituted with a variety of groups. The compounds all show markedly low toxicities and a number show very high levels of water solubility.
Inventor(s): Almen; Torsten (Oslo, NO), Haavaldsen; Johan (Oslo, NO), Nordal; Vegard (Oslo, NO)
Assignee: Nyegaard & Co. A/S (Oslo, NO)
Application Number:05/528,842
Patent Claims: 1. A non-ionic X-ray contrast compound of the formula ##STR8## where R.sup.1 and R.sup.2, which may be the same or different, are each a hydrogen atom, an alkyl group, a hydroxyalkyl group or an alkanoyloxyalkyl group and R.sub.3 and R.sup.4, which may be the same or different, are each a group of the formula --NR.sup.5 Ac, where R.sup.5 is a hydrogen atom, an alkyl group, a hydroxyalkyl group, an alkanoyloxyalkyl group or an alkanoyl group and Ac is an alkanoyl group; a group of the formula --CH.sub.2 NR.sup.5 Ac, where R.sup.5 and Ac have the above meanings; or a group ##STR9## as defined above; each alkyl, hydroxyalkyl or alkanoyl group which is present having up to 6 carbon atoms there being at least one N-hydroxyalkyl and at least two hydroxyl groups in the molecule.

2. A compound as claimed in claim 1 in which at least one of R.sup.1 and R.sup.2 is an alkyl group or a hydroxyalkyl group.

3. A compound as claimed in claim 1 having at least one group of the formula --NR.sup.5 Ac in which R.sup.5 is a hydrogen atom, an alkyl group, a hydroxyalkyl group or an alkanoyloxyalkyl group.

4. A compound as claimed in claim 1 having at least one hydroxyalkyl group which is a .beta.-hydroxyethyl, dihydroxypropyl or tris-(hydroxymethyl)-methyl group.

5. A compound as claimed in claim 1 selected from the group consisting of 3,5-bis-N-di-(.beta.-hydroxyethyl)-carbamoyl-2,4,6-triiodoacetanilide; 3,5-bis-N-(2', 3'-dihydroxypropyl)-carbamoyl-2,4,6-triiodoacetanilide N-(3-N-methylacetamide-2,4,6-triiodobenzoyl)-glucamine; N-(3-diacetylamino-5-N-methylacetamido-2,4,6-triiodo-benzoyl)-N-methylgluc amine; N-(N-methyl-3,5-diacetamide-2,4,6-triiodobenzoyl)-N-methyl glucamine; N-[3-N-(.beta.-hydroxyethyl)-acetamido-5-N-methylacetamido-2,4, 6-triiodobenzoyl]-N-methyl-2,3-dihydroxypropylamine; N-[N,N'-di-(.beta.-hydroxyethyl)-3,5-diacetamido-2,4,6-triiodobenzoyl]-die thanolamine; 3-Acetamido-5-N-methylcarbamoyl-2,4,6-triiodobenzoyl)-N-methylglucamine; N-(3-acetamido-5-acetamidomethyl-2,4,6-triiodobenzoyl)-N-methylglucamine; 3,5-Bis[N-2,3-dihydroxypropyl)-N-methylcarbamoyl]-2,4,6-triiodoacetanilide ; N-(N-methyl-3,5-diacetamido-2,4,6-triiodobenzoyl-2-glucamine; N-(3,5-diacetamido-2,4,6-triiodobenzoyl)-glucamine; N-(3,5-diacetamido-2,4,6-triiodobenzoyl)-2-glucamine; 3,5-Bis[N-2', 3'-dihydroxypropyl)-N-methylcarbamoyl]-N-2'-hydroxyethyl)-2,4,6-triiodoace tanilide; N-(3-acetamido-5-N-methylcarbamoyl-2,4,6-triiodobenzoyl)-D-2-glucamine; N-(3-acetamido-5-N-methylcarbamoyl-2,4,6-triiodobenzoyl)-D-1-glucamine; N-(3-.beta.-hydroxyethylacetamido-5-N-methylcarbamoyl-2,4,6-triiodobenzoyl )-D-2-glucamine; N-(3N-.beta.-hydroxyethylacetamido-5-N-methylcarbamoyl-2,4,6-triiodobenzoy l)-D-1-glucamine; N-(3,5-diacetamido-2,4,6-triiodobenzoyl)-N-methyl-glucamine; N-(N-methyl-3,5-diacetamido-2,4,6-triiodobenzoyl)-D-glucamine; N-(N-methyl-3,5-diacetamido-2,4,6-triiodobenzoyl)-N,N-di-(.beta.-hydroxyet hyl)-amine; N-[3-N-methylacetamido-5-N-(.beta.-hydroxyethyl)-acetamido-2,4,6-triiodobe nzoyl]-N-methylglucamine; N-[3-N-methylacetamido-5-N-(.beta.-acetoxyethyl)-acetamido-2,4,6-triiodobe nzoyl]-N-methylglucamine; N-[3-N-methylacetamido-5-N-(.beta.-hydroxyethyl)-acetamido-2,4,6-triiodobe nzoyl]-ethanolamine; N-[3N-methylacetamido-5-N-(.beta.-hydroxyethyl)-acetamido-2,3,6-triiodoben zoyl]-N-methyethanolamine; N-[3-N-methlacetamido-5-N-(.beta.-hydroxyethyl)acetamido-2,4,6 -triiodobenzoyl]-diethanolamine; N-[3-N-methylacetamido-5-N-(.beta.-hydroxyethyl)-acetamido-2,4,6-triiodobe nzoyl]-N-(2,3,dihydroxypropyl)-amine; N-[3-N-methylacetamido-5-N-(.beta.-hydroxyethyl)-acetamido-2,4,6-triiodobe nzoyl]-N-[tris-(hydroxymethyl)-methyl]-amine; N-[3-N-methylacetamido-5-N-(2,3-dihydroxypropyl)-acetamido-2,4,6-triiodobe nzoyl]-N-methylglucamine; N-[3-5-bis-N-(.beta.-hydroxyethyl)-acetamido2,4,6-triiodobenzoyl-N-methyl- glucamine; N-[3,5-bis-N-(.beta.-hydroxyethyl)-acetamido-2,4,6triiodobenzoyl]-N-methyl -N-(2,3-dihydroxypropyl)-amine; N-[3,5-bis-N-(.beta.-hydroxyethyl-acetamido-2,4,6 -triiodobenzoyl]-ethanolamine and N-[3-acetamido-5N-methylcarbamoyl-2,4,6-triiodobenzoyl]-N-(2-hydroxyethyl) -glucamine.

6. The compound of claim 1 which is N-(3-acetamido-5-N-methylcarbamoyl-2,4,6-triiodobenzoyl)-N-(2-hydroxyethyl )-glucamine.

7. The compound of claim 1 which is N-(3-acetamido-5-N-methylcarbamoyl-2,4,6-triiodobenzoyl)-N-methylglucamine

8. The compound of claim 1 which is 3,5-bis-[N-(2,3-dihydroxypropyl)-N-methylcarbamoyl]-2,4,6-triiodoacetanili de.

9. A non-ionic X-ray contrast compound which is N,N'-bis-[3-di-(.beta.-hydroxyethyl)-aminocarbonyl-2,4,6-triiodophenyl]-ad ipamide or N,N'-bis-[3-(N-methyl)-glucaminocarbonyl-2,4,6-triiodophenyl]-adipamide.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
US Army
Queensland Health
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.